Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released a note authored by inventor and ...

The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. WALTHAM, ...

Transfusion of the ‘wrong’ stem cell product would almost inevitably be lethal, yet assays to confirm the contents of the product bag, except by checking labels and paperwork, are lacking. To increase ...

Dr. Michael Linenberger of Fred Hutchinson Cancer Research Center has been awarded one of the highest honors in the field of apheresis, the medical subspecialty that uses automated methods to separate ...

TEL AVIV, Israel, April 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases ...

LAS VEGAS — Lipid apheresis can significantly reduce lipoprotein(a) levels compared with available drug therapies, according to a presentation at National Lipid Association Scientific Sessions.

In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...